Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Context: The increased use of opioids has resulted in an unprecedented opioid epidemic. Chronic opioid use causes hypogonadism, but its frequency, as well as the effects of opioids on other hypothalamo–pituitary–end organ hormone axes, remains unclear. Objective: The aim of this systematic review and meta-analysis was to assess the effects of opioid use on pituitary function. Methods: Eight electronic databases were searched for articles published up to May 8, 2018. Fixed or random effects meta-analysis was performed to estimate pooled proportions with 95% confidence intervals (CI). This study is reported following the PRISMA and MOOSE guidelines. Data synthesis: 52 studies (22 low risk of bias) were included describing 18 428 subjects, consisting of patients with chronic pain (n = 21 studies) or on maintenance treatment for opioid addiction (n = 9) and healthy volunteers (n = 4). The most frequently used opioid was methadone (n = 13 studies), followed by morphine (n = 12). Prevalence of hypogonadism was 63% (95% CI: 55%–70%, 15 studies, 3250 patients, 99.5% males). Prevalence of hypocortisolism relying on dynamic and nondynamic testing was 15% (95% CI: 6%–28%, 5 studies, 205 patients, 57.5% males) and including only studies using the insulin tolerance tests 24% (95% CI 16%–33%, 2 studies, n = 97 patients). In 5 out of 7 studies, hyperprolactinemia was present. No clear effects on the somatotropic and hypothalamo–pituitary–thyroid axes were described. Conclusions: Hypogonadism occurs in more than half of male opioid users, and hypocortisolism in approximately one-fifth of all patients. Periodical evaluation of at least the gonadal and adrenal axes is therefore advisable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these reports, there was a weighted mean percentage of 15% (95% CI, 6-28) with secondary adrenal insufficiency (72).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a systematic review of 6 studies evaluating the long-term effects of opioids on PRL secretion among 346 patients with either cancer pain or noncancer pain, the results were variable (72).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The limited number of included reports and the different protocols used to assess GH deficiency did not allow definite conclusions to be obtained (72).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Trends in Opioid Analgesic Abuse and Mortality in the United States
Dart, R. C., Surratt, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsa1406143 · Cited by 1,137
Long-term opioid management for chronic noncancer pain
Noble, M., Treadwell, J. R., Tregear, S. J., Coates, V. H., Wiffen, P. J., Akafomo, C., Schoelles, K. M., & Chou, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006605.pub2 · Cited by 735
Endocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401
The impact of opioids on the endocrine system
Katz, N., & Mazer, N. A. (2009) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181850df6 · Cited by 307
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263
Bliesener, N., Albrecht, S., Schwager, A., Weckbecker, K., Lichtermann, D., & Klingmüller, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0929 · Cited by 236
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 166
The Public and the Opioid-Abuse Epidemic
Blendon, R. J., & Benson, J. M. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1714529 · Cited by 158
Rhodin, A., Stridsberg, M., & Gordh, T. (2010) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e3181d1059d · Cited by 142
Basaria, S., Travison, T. G., Alford, D., Knapp, P. E., Teeter, K., Cahalan, C., Eder, R., Lakshman, K., Bachman, E., Mensing, G., et al. (2015) · Pain · doi:10.1097/01.j.pain.0000460308.86819.aa · Cited by 125
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment
Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., & Attia, J. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2007.00824.x · Cited by 124
Testosterone suppression in opioid users: A systematic review and meta-analysis
Bawor, M., Bami, H., Dennis, B. B., Plater, C., Worster, A., Varenbut, M., Daiter, J., Marsh, D. C., Steiner, M., Anglin, R., et al. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.01.038 · Cited by 123
Zhang, G.-F., Ren, Y.-P., Sheng, L.-X., Chi, Y., Du, W.-J., Guo, S., Jiang, Z.-N., Xiao, L., Luo, X.-N., Tang, Y.-L., et al. (2008) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990802385781 · Cited by 105
Testosterone deficiency in non-cancer opioid-treated patients
Coluzzi, F., Billeci, D., Maggi, M., & Corona, G. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0964-3 · Cited by 81
Opioid-Induced Adrenal Insufficiency
Donegan, D., & Bancos, I. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.010 · Cited by 78
Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients
Aloisi, A., Ceccarelli, I., Carlucci, M., Suman, A., Sindaco, G., Mameli, S., Paci, V., Ravaioli, L., Passavanti, G., Bachiocco, V., et al. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-26 · Cited by 77
Opioid Related Endocrinopathy: Table 1
Gudin, J. A., Laitman, A. P., & Nalamachu, S. R. (2015) · Pain Medicine · doi:10.1111/pme.12926 · Cited by 74
Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment
Aloisi, A. M., Buonocore, M., Merlo, L., Galandra, C., Sotgiu, A., Bacchella, L., Ungaretti, M., Demartini, L., & Bonezzi, C. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.017 · Cited by 72
Male hypogonadism associated with advanced cancer: a systematic review
Vigano, A. A. L., Piccioni, M., Trutschnigg, B., Hornby, L., Chaudhury, P. K., & Kilgour, R. D. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70021-8 · Cited by 60
MECHANISMS OF ENDOCRINOLOGY: endocrinology of opioids
Fountas, A., Chai, S. T., Kourkouti, C., & Karavitaki, N. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0270 · Cited by 60
Self-citationDuarte, R. V., Raphael, J. H., Southall, J. L., Labib, M. H., Whallett, A. J., & Ashford, R. L. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002856 · Cited by 55
Elucidating risk factors for androgen deficiency associated with daily opioid use
Rubinstein, A., & Carpenter, D. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.07.015 · Cited by 53
Adrenal insufficiency in patients on long-term opioid analgesia
Gibb, F. W., Stewart, A., Walker, B. R., & Strachan, M. W. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13125 · Cited by 52
Lamprecht, A., Sorbello, J., Jang, C., Torpy, D. J., & Inder, W. J. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0530 · Cited by 52
Blick, G., Khera, M., Bhattacharya, R. K., Nguyen, D., Kushner, H., & Miner, M. M. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2012.01368.x · Cited by 45
Rubinstein, A. L., & Carpenter, D. M. (2017) · Pain Medicine · doi:10.1093/pm/pnw182 · Cited by 44
Valverde-Filho, J., Cunha Neto, M. B. C. D., Fonoff, E. T., Meirelles, E. D. S., & Teixeira, M. J. (2015) · Pain Medicine · doi:10.1111/pme.12661 · Cited by 37
Singh, D., Murugaiyah, V., Hamid, S. B. S., Kasinather, V. B., Chan, M. S. A., Ho, E. T. W., Grundmann, O., Chear, N. J., & Mansor, S. M. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.04.005 · Cited by 36
Wong, D., Gray, D., Simmonds, M., Rashiq, S., Sobolev, I., & Morrish, D. W. (2011) · Pain Research and Management · doi:10.1155/2011/807123 · Cited by 32
Nenke, M. A., Haylock, C. L., Rankin, W., Inder, W. J., Gagliardi, L., Eldridge, C., Rolan, P., & Torpy, D. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.03.015 · Cited by 32
Opioid endocrinopathy: a clinical problem in patients with cancer pain
MERDIN, A., MERDIN, F. A., GÜNDÜZ, Ş., BOZCUK, H., & COŞKUN, H. Ş. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3156 · Cited by 32
Drug-induced HPA axis alterations during acute critical illness: a multivariable association study
Peeters, B., Güiza, F., Boonen, E., Meersseman, P., Langouche, L., & Van den Berghe, G. (2017) · Clinical Endocrinology · doi:10.1111/cen.13155 · Cited by 31
Raheem, O. A., Patel, S. H., Sisul, D., Furnish, T. J., & Hsieh, T.-C. (2017) · American Journal of Men's Health · doi:10.1177/1557988316672396 · Cited by 29
Chronic Use of Opioids and the Endocrine System
Merza, Z. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1254099 · Cited by 27
Morphine-induced TSH release in normal and hypothyroid subjects
Devilla, L., Pende, A., Morgano, A., Giusti, M., Musso, N. R., & Lotti, G. (2008) · Neuroendocrinology · doi:10.1159/000124091 · Cited by 27
Yee, A., Loh, H. S., Danaee, M., Riahi, S., Ng, C. G., & Sulaiman, A. H. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.12.004 · Cited by 27
Yang, J., Li, J., Xu, G., Zhang, J., Chen, Z., Lu, Z., & Deng, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150729 · Cited by 24
Gerber, H., Borgwardt, S. J., Schmid, O., Gerhard, U., Joechle, W., Riecher-Rössler, A., Wiesbeck, G. A., & Walter, M. (2012) · European Addiction Research · doi:10.1159/000334411 · Cited by 20
A systematic review of opioid effects on the hypogonadal axis of cancer patients
McWilliams, K., Simmons, C., Laird, B. J., & Fallon, M. T. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2195-2 · Cited by 20
Endocrine effects of methadone in rats; acute effects in adults
Bartolome, M. B., & Kuhn, C. M. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90639-8 · Cited by 17
Androgen Deficiency in Long-Term Intrathecal Opioid Administration
Kim, C., Garcia, R., Stover, J., Ritchie, K., Whealton, T., & Ata, M. A. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/e543 · Cited by 17
Huang, G. T.-W., Travison, T. G., Edwards, R. R., & Basaria, S. S. (2016) · Pain Medicine · doi:10.1093/pm/pnw159 · Cited by 16
LOPERAMIDE, AN OPIATE ANALOGUE, INHIBITS PLASMA ACTH LEVELS IN PATIENTS WITH ADDISON'S DISEASE
Ambrosi, B., Bochicchio, D., & Faglia, G. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb03276.x · Cited by 15
Finch, P. M., Price, L. M., Pullan, P. T., & Drummond, P. D. (2015) · Pain Practice · doi:10.1111/papr.12190 · Cited by 15
Armstrong, J. D., & Spears, J. W. (1991) · Journal of Animal Science · doi:10.2527/1991.692774x · Cited by 13
Auernhammer, C. J., Riepl, R. L., Schopohl, J., Lehnert, P., Müller, O. A., & Stalla, G. K. (2008) · Neuroendocrinology · doi:10.1159/000126715 · Cited by 10
Edgerton, L., & Loven, B. (2011) · PubMed · Cited by 7
What are the adverse effects of prolonged opioid use in patients with chronic pain
Edgerton, L., & Loven, B. (2011) · MOspace Institutional Repository (University of Missouri) · Cited by 2
Supplementary data to the paper: Opioids and their endocrine effects.
Zamanipoor Najafabadi, A. (2019) · Figshare · doi:10.4121/uuid:983ea5a3-3914-4fad-814a-f7af41ddbf43
Self-citation
Cited by
Moisset, X., Bouhassira, D., Avez Couturier, J., Alchaar, H., Conradi, S., Delmotte, M. H., Lanteri-Minet, M., Lefaucheur, J. P., Mick, G., Piano, V., et al. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.01.361 · Cited by 450
Corona, G., Goulis, D. G., Huhtaniemi, I., Zitzmann, M., Toppari, J., Forti, G., Vanderschueren, D., & Wu, F. C. (2020) · Andrology · doi:10.1111/andr.12770 · Cited by 431
Petersenn, S., Fleseriu, M., Casanueva, F. F., Giustina, A., Biermasz, N., Biller, B. M. K., Bronstein, M., Chanson, P., Fukuoka, H., Gadelha, M., et al. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00886-5 · Cited by 411
“Many drugs acting as dopamine antagonists or as serotonin agonists can cause hyperprolactinaemia and galactorrhoea 53–55 (Box 2).”
BackgroundSelf-citationHahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Yennurajalingam, S., Arthur, J. A., Reddy, S., Edwards, T., Lu, Z., de Moraes, A. R., Wilson, S. M., Erdoğan, E., Joy, M. P., Ethridge, S. D., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2020.6789 · Cited by 95
Metadata
- Authors
- de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H.
- Affiliations
- Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands
- Leiden University Medical Center (NL)
- Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Centre for Endocrine Tumors Leiden (CETL), Leiden University Medical Center, Leiden, The Netherlands
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-09-12
- Volume
- 105
- Issue
- 4
- Pages
- 1020-1029
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC7054712
- OpenAlex
- W2970372933
- Semantic Scholar
- 1c1947dedebd9bb7887038dc2478f0a6c5ad8fb7
- Cited by
- 139
- References
- 57
- Citations by year
- 2026: 15 · 2025: 26 · 2024: 24 · 2023: 13 · 2022: 26 · 2021: 23 · 2020: 10 · 2019: 1
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- opioids, chronic opioid use, hypogonadism, adrenal insufficiency, hyperprolactinemia, pituitary function, hypothalamic-pituitary-adrenal axis, hypothalamic-pituitary-gonadal axis, methadone, morphine, chronic pain, insulin tolerance test
- MeSH terms
- Analgesics, Opioid, Endocrine System Diseases, Humans, Hypogonadism, Pituitary Hormones, Prognosis, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.